WebTocilizumab is an interleukin-6 (IL-6) receptor antagonist used to treat Cytokine Release Syndrome (CRS), Systemic Juvenile Idiopathic Arthritis ... ACTEMRA (tocilizumab) injection, for intravenous or subcutaneous use (December 2024) External Links KEGG Drug D02596 PubChem Substance 347910344 RxNav 612865 ChEMBL … Web11 ago 2024 · RoActemra is supplied as a 0.9 mL pre-filled pen containing 162 mg tocilizumab solution for injection. Each pack contains 4 pre-filled pens with multipacks containing 12 (3 packs of 4) pre-filled pens.
Tocilizumab Uses, Side Effects & Warnings - Drugs.com
Web1 mag 2024 · Tocilizumab is marketed in the UK by Roche Products Limited as RoActemra, in solutions containing 162 mg for injection (pens and syringes) and as a 20 mg/mL … Web托珠单抗(INN药名 tocilizumab;又名 atlizumab ;商品名 雅美罗、Actemra)是一种主要治疗类风湿关节炎和幼年特发性关节炎的免疫抑制药。 本药是针对白细胞介素-6受体(IL-6R)的 人源单克隆抗体 ( 英语 : humanized antibody ) 。 白细胞介素-6(IL-6)是一种细胞因子,在免疫反应中有重要作用,与许多 ... scrunched up tissue paper
Actemra 400mg Injection 1
WebWithdraw a volume of sterile, non-pyrogenic sodium chloride 0.9% solution for injection from a 100 ml infusion bag, equal to the volume of tocilizumab concentrate required for … Web3 apr 2024 · RoActemra 162 mg Solution for Injection in Pre-Filled Syringe Active Ingredient: tocilizumab Company: Roche Products Limited See contact details ATC code: L04AC07 About Medicine Prescription only medicine Healthcare Professionals (SmPC) … Tocilizumab SC formulation is administered with a single-use PFS+NSD. Treatment … Tocilizumab SC formulation is administered with a single-use PFS+NSD. Treatment … RoActemra 162 mg Solution for Injection in Pre-Filled Syringe - Patient Information … RoActemra (tocilizumab) Important Safety Information for Patients. This material is … tocilizumab. Save this search Back to top. 3 results found Filters. Filter by. Medicine … Enter your search term here... Search Login to submit a new ticket Web17 feb 2024 · Tocilizumab should not be used in combination with biologic DMARDs. IV: Initial: 4 mg/kg once every 4 weeks; may be increased to 8 mg/kg once every 4 weeks based on clinical response (maximum dose: 800 mg). <100 kg: 162 mg once every other week; increase to 162 mg once every week based on clinical response. scrunched up tissue paper art